Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
ChemoCentryx, Inc. (0001340652)
Standardized SEC financial data for ChemoCentryx, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001340652 · Pharmaceutical Preparations.
Income statement
USD
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
Revenue
$11.9M
$82.5M
$42.9M
$36.1M
$64.9M
$32.2M
R&D expense
$37.9M
$49.5M
$62.7M
$70.3M
$77.9M
$83.0M
SG&A expense
$14.7M
$16.5M
$20.4M
$24.2M
$42.2M
$78.9M
Operating income
-$40.7M
$16.5M
-$40.3M
-$58.3M
-$55.2M
-$129.9M
Interest expense
—
$4K
$1.2M
$2.1M
$2.6M
$2.7M
Income tax
$0
$0
$0
$0
$0
$0
Net income
-$40.0M
$17.9M
-$38.0M
-$55.5M
—
—
EPS (diluted)
$-0.86
$0.36
$-0.76
$-0.98
—
—
Standardized from ChemoCentryx, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.